Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prohibitin pseudogene 17 (PHB1P17) is a processed pseudogene related to the prohibitin 1 (PHB1) gene family. Pseudogenes do not encode functional proteins and therefore do not have intrinsic biological activities, recognized disease roles, or established pharmaceutical targeting relevance. The closely related PHB1 gene (prohibitin 1) encodes a mitochondrial chaperone implicated in mitochondrial integrity, tumor suppression, and cellular signaling, but PHB1P17 is a pseudogene and not a direct target for drugs or therapeutic intervention. PHB1P17 lacks documented biological or pathological functions, drug interactions, mechanism of action, or disease association. This entry appears to be either misattributed as a therapeutic target (since it is not an active molecule), or only relevant in reference to its parent gene, PHB1. If you are interested in functional information about prohibitin 1 (PHB1) itself, that is a separate, functionally significant mitochondrial protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prohibitin pseudogene 17 (PHB1P17).